Medpace Holdings Ownership
| MEDP Stock | USD 319.63 7.84 2.39% |
Shares in Circulation | First Issued 2014-03-31 | Previous Quarter 32.1 M | Current Value 31.9 M | Avarage Shares Outstanding 36.6 M | Quarterly Volatility 3.1 M |
Medpace |
Medpace Stock Ownership Analysis
About 19.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.79. Medpace Holdings recorded earning per share (EPS) of 12.64. The entity had not issued any dividends in recent years. Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company was founded in 1992 and is based in Cincinnati, Ohio. Medpace Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 5000 people. To find out more about Medpace Holdings contact August MD at (513) 579-9911 or learn more at https://www.medpace.com.Besides selling stocks to institutional investors, Medpace Holdings also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Medpace Holdings' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Medpace Holdings' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Medpace Holdings Quarterly Liabilities And Stockholders Equity |
|
Medpace Holdings Insider Trades History
About 19.0% of Medpace Holdings are currently held by insiders. Unlike Medpace Holdings' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Medpace Holdings' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Medpace Holdings' insider trades
Medpace Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Medpace Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medpace Holdings backward and forwards among themselves. Medpace Holdings' institutional investor refers to the entity that pools money to purchase Medpace Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Td Asset Management Inc | 2024-12-31 | 464 K | Goldman Sachs Group Inc | 2024-12-31 | 441.2 K | Capital World Investors | 2024-12-31 | 438.4 K | Td Global Investment Solutions – Td Epoch | 2024-12-31 | 438.1 K | Clearbridge Advisors, Llc | 2024-12-31 | 409.7 K | American Capital Management Inc | 2024-12-31 | 329.4 K | Gw&k Investment Management, Llc | 2024-12-31 | 275.5 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 267.9 K | Spyglass Capital Management Llc | 2024-12-31 | 262.7 K | Blackrock Inc | 2024-12-31 | 2.7 M | Vanguard Group Inc | 2024-12-31 | 2.6 M |
Medpace Holdings Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medpace Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medpace Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medpace Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Medpace Holdings' latest congressional trading
Congressional trading in companies like Medpace Holdings, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Medpace Holdings by those in governmental positions are based on the same information available to the general public.
| 2024-08-15 | Representative Josh Gottheimer | Acquired Under $15K | Verify |
Medpace Holdings Outstanding Bonds
Medpace Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medpace Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medpace bonds can be classified according to their maturity, which is the date when Medpace Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| US58506YAS19 Corp BondUS58506YAS19 | View | |
| MEDTRONIC INC 4375 Corp BondUS585055BT26 | View | |
| MEDTRONIC INC 4625 Corp BondUS585055BU98 | View | |
| US58502BAE65 Corp BondUS58502BAE65 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Medpace Holdings Corporate Filings
| 11th of March 2025 Other Reports | ViewVerify | |
F4 | 10th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 24th of February 2025 Other Reports | ViewVerify | |
10K | 11th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
Pair Trading with Medpace Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.Moving together with Medpace Stock
Moving against Medpace Stock
| 0.58 | CMRX | Chimerix Sell-off Trend | PairCorr |
| 0.48 | LUNG | Pulmonx Corp | PairCorr |
| 0.44 | CPIX | Cumberland Pharmaceuticals | PairCorr |
| 0.44 | LUCD | Lucid Diagnostics Buyout Trend | PairCorr |
The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.
The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medpace Stock Analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.